Table Of Contents:

1 Introduction 6 1.1 Industry Definition and Research Scope 6 1.1.1 Industry Definition 6 1.1.2 Research Scope 7 1.2 Research Methodology 10 1.2.1 Overview of Market Research Methodology 10 1.2.2 Market Assumption 11 1.2.3 Secondary Data 11 1.2.4 Primary Data 11 1.2.5 Data Filtration and Model Design 12 1.2.6 Market Size/Share Estimation 13 1.2.7 Research Limitations 14 1.3 Executive Summary 15 2 Market Overview and Dynamics 17 2.1 Market Size and Forecast 17 2.1.1 Impact of COVID-19 on World Economy 18 2.1.2 Impact of COVID-19 on the Market 20 2.2 Major Growth Drivers 22 2.3 Market Restraints and Challenges 29 2.4 Emerging Opportunities and Market Trends 32 2.5 Porter’s Fiver Forces Analysis 36 3 Segmentation of North America Market by Onychomycosis Type 40 3.1 Market Overview by Onychomycosis Type 40 3.2 Distal Subungual Onychomycosis 42 3.3 White Superficial Onychomycosis 43 3.4 Proximal Subungual Onychomycosis 44 3.5 Candidal Onychomycosis 45 3.6 Other Onychomycosis Types 46 4 Segmentation of North America Market by Treatment Type 47 4.1 Market Overview by Treatment Type 47 4.2 Drug Treatment 49 4.3 Laser Therapy 50 4.4 Photodynamic Therapy 51 4.5 Other Therapies 52 5 Segmentation of North America Market by Distribution Channel 53 5.1 Market Overview by Distribution Channel 53 5.2 Hospitals and Clinics 55 5.3 Online Stores 56 5.4 Retail Pharmacies 57 5.5 Other Distribution Channels 58 6 North America Market 2021-2031 by Country 59 6.1 Overview of North America Market 59 6.2 U.S. 62 6.3 Canada 65 6.4 Mexico 67 7 Competitive Landscape 69 7.1 Overview of Key Vendors 69 7.2 New Product Launch, Partnership, Investment, and M&A 72 7.3 Company Profiles 73 Bausch Health Companies Inc. 73 Bayer AG 75 Cipla Ltd 76 Dr. Reddys Laboratories Ltd 77 Galderma SA 78 GlaxoSmithKline PLC 79 Johnson & Johnson 80 Lumenis Ltd 81 Medimetriks Pharmaceuticals Inc. 82 Moberg Pharma AB 83 Novartis AG 84 Pfizer Inc. 85 Sanofi SA 86 RELATED REPORTS 87

List Of Tables:


Table 1.  Snapshot of North America Onychomycosis Treatment Market in Balanced Perspective, 2021-2031 16
Table 2. World Economic Outlook, 2021-2031 19
Table 3. Clinical Trials of Onychomycosis Treatment 25
Table 4. World Health Spending by Region, $ bn, 2013-2020 28
Table 5.  Main Product Trends and Market Opportunities in North America Onychomycosis Treatment Market 32
Table 6. North America Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 40
Table 7. North America Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 47
Table 8. North America Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 53
Table 9. North America Onychomycosis Treatment Market by Country, 2021-2031, $ mn 60
Table 10. U.S. Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 64
Table 11. U.S. Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 64
Table 12. U.S. Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 64
Table 13. Canada Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 66
Table 14. Canada Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 66
Table 15. Canada Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 66
Table 16. Mexico Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 68
Table 17. Mexico Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 68
Table 18. Mexico Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 68
Table 19. Bausch Health Companies Inc.: Company Snapshot 73
Table 20. Bausch Health Companies Inc.: Business Segmentation 74
Table 21. Bausch Health Companies Inc.: Product Portfolio 74

List Of Figures:


Figure 1. Research Method Flow Chart 10
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 13
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 15
Figure 4. North America Onychomycosis Treatment Market, 2021-2031, $ mn 17
Figure 5. Impact of COVID-19 on Business 20
Figure 6. Primary Drivers and Impact Factors of North America Onychomycosis Treatment Market 22
Figure 7.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 26
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 27
Figure 9. Primary Restraints and Impact Factors of North America Onychomycosis Treatment Market 29
Figure 10. Investment Opportunity Analysis 33
Figure 11. Porter’s Fiver Forces Analysis of North America Onychomycosis Treatment Market 36
Figure 12. Breakdown of North America Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, % of Revenue 41
Figure 13. North America Addressable Market Cap in 2022-2031 by Onychomycosis Type, Value ($ mn) and Share (%) 41
Figure 14. North America Onychomycosis Treatment Market by Onychomycosis Type: Distal Subungual Onychomycosis, 2021-2031, $ mn 42
Figure 15. North America Onychomycosis Treatment Market by Onychomycosis Type: White Superficial Onychomycosis, 2021-2031, $ mn 43
Figure 16. North America Onychomycosis Treatment Market by Onychomycosis Type: Proximal Subungual Onychomycosis, 2021-2031, $ mn 44
Figure 17. North America Onychomycosis Treatment Market by Onychomycosis Type: Candidal Onychomycosis, 2021-2031, $ mn 45
Figure 18. North America Onychomycosis Treatment Market by Onychomycosis Type: Other Onychomycosis Types, 2021-2031, $ mn 46
Figure 19. Breakdown of North America Onychomycosis Treatment Market by Treatment Type, 2021-2031, % of Sales Revenue 48
Figure 20. North America Addressable Market Cap in 2022-2031 by Treatment Type, Value ($ mn) and Share (%) 48
Figure 21. North America Onychomycosis Treatment Market by Treatment Type: Drug Treatment, 2021-2031, $ mn 49
Figure 22. North America Onychomycosis Treatment Market by Treatment Type: Laser Therapy, 2021-2031, $ mn 50
Figure 23. North America Onychomycosis Treatment Market by Treatment Type: Photodynamic Therapy, 2021-2031, $ mn 51
Figure 24. North America Onychomycosis Treatment Market by Treatment Type: Other Therapies, 2021-2031, $ mn 52
Figure 25. Breakdown of North America Onychomycosis Treatment Market by Distribution Channel, 2021-2031, % of Sales Revenue 54
Figure 26. North America Addressable Market Cap in 2022-2031 by Distribution Channel, Value ($ mn) and Share (%) 54
Figure 27. North America Onychomycosis Treatment Market by Distribution Channel: Hospitals and Clinics, 2021-2031, $ mn 55
Figure 28. North America Onychomycosis Treatment Market by Distribution Channel: Online Stores, 2021-2031, $ mn 56
Figure 29. North America Onychomycosis Treatment Market by Distribution Channel: Retail Pharmacies, 2021-2031, $ mn 57
Figure 30. North America Onychomycosis Treatment Market by Distribution Channel: Other Distribution Channels, 2021-2031, $ mn 58
Figure 31. Breakdown of North America Onychomycosis Treatment Market by Country, 2021 and 2031, % of Revenue 60
Figure 32. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 61
Figure 33. U.S. Onychomycosis Treatment Market, 2021-2031, $ mn 63
Figure 34. Canada Onychomycosis Treatment Market, 2021-2031, $ mn 65
Figure 35.  Onychomycosis Treatment Market in Mexico, 2021-2031, $ mn 67
Figure 36. Growth Stage of North America Onychomycosis Treatment Industry over the Forecast Period 69

Selected Key Players: 
Bausch Health Companies Inc.
Bayer AG
Cipla Ltd
Dr. Reddys Laboratories Ltd
Galderma SA
GlaxoSmithKline PLC
Johnson & Johnson
Lumenis Ltd
Medimetriks Pharmaceuticals Inc.
Moberg Pharma AB
Novartis AG
Pfizer Inc.
Sanofi SA 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)